Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Political Calculations (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

S&P 500 Chases After Bad News Toward New High

% of readers think this story is Fact. Add your two cents.


Editorial cartoon of a bull running away from a boy who is selling newspapers, with the boy running behind the bull, both running up a hill image. Generated with Microsoft Bing Image Creator

For a week that had more negative than positive headlines, the S&P 500 (Index: SPX) perhaps surprisingly turned in a pretty good week. The index rose 1.8% to 4,783.83.

That puts the S&P 500 less than 13 points away from breaking it’s all-time high closing value of 4,796.56, which is set on 3 January 2022.

We say “perhaps surprisingly” because in the current market environment, negative headlines focus investors on the very near term, in which the outlook for dividend growth is positive. The newest update to the dividend futures-based model‘s alternative futures chart indicates the trajectory of the S&P 500 is consistent with investors focusing their forward-looking attention on 2024-Q1 as we come to the end of the current redzone forecast range.

Alternative Futures - S&P 500 - 2024Q1 - Standard Model (m=+1.5 from 9 March 2023) - Snapshot on 12 Jan 2024

Why would negative headlines prompt investors to focus on the current quarter? It has everything to do with the expected timing of when the Federal Reserve will be forced to begin cutting interest rates to address a slowing U.S. economy. After the week’s headlines, the CME Group’s FedWatch Tool projects the Fed will hold the Federal Funds Rate steady in a target range of 5.25-5.50% until 20 March 2023 (2024-Q1), when investors anticipate it will launch a series of quarter point rate cuts at six-to-twelve-week intervals through the end of 2024 are anticipated.

In the current market environment, that leads to rising stock prices. At least until fading economic conditions might reduce the expectations for dividend growth in future quarters and investors shift their attention accordingly. When that happens, bad news will become bad news for the trajectory of stock prices.

Speaking of which, here are the past week’s market-moving headlines:

Monday, 8 January 2024
  • Signs and portents for the U.S. economy:
  • Fed minion says rate hikes are done:
  • Nasdaq adds +2%, S&P, Dow also gain as tech stocks offset a slide in Boeing
  • Tuesday, 9 January 2024
    • Signs and portents for the U.S. economy:
  • BOJ minions get reason to keep never-endng stimulus alive as inflation continues biting:
  • Bigger trouble developing in the Eurozone:
  • Euro zone’s services sector may slow further, ECB says
  • ECB minions thinking about cutting rates sooner:
  • Dow, S&P 500 retreat as yields edge up ahead of data, earnings
  • Wednesday, 10 January 2024
    • Signs and portents for the U.S. economy:
  • Fed minions say they’re not sure they’re not done fighting inflation:
  • Questions raised and some positive signs developing in China:
  • Bigger trouble developing in the Eurozone:
  • Stocks climb as megacaps lead; inflation data, earnings on deck
  • Thursday, 11 January 2024
    • Signs and portents for the U.S. economy:
  • US power prices soar ahead of extreme cold and record natgas demand
  • Oil up 1% as Middle East tensions offset US inflation worries
  • US startup funding drops 30% in 2023 despite AI frenzy
  • Fed minions say higher-than-expected inflation report no biggie for them:
  • BOJ minions solve inflation:
  • ECB minions dangle interest rate cuts if inflation falls lower:
  • Nasdaq, S&P, Dow end little changed after inflation data sparks volatile trading session
  • Friday, 12 January 2024
    • Signs and portents for the U.S. economy:
  • ‘Remarkable’ surge in auto insurance costs fans US inflation
  • Flagging loan margins, one-off charges drag down profit at major US banks
  • Fed minions are losing money:
  • Mixed economic signs developing in China:
  • ECB minions claim they’re not cutting interest rates anytime soon:
  • Stocks end little changed as earnings offset inflation data
  • The Atlanta Fed’s GDPNow tool‘s estimate of real GDP growth for the current quarter of 2023-Q4 declined to +2.2% from the +2.5% it projected last week. The Atlanta Fed’s projections for GDP growth in 2023-Q4 will continue through 19 January 2024; it will be replaced by the BEA’s initial estimate of that growth in the following week. The Atlanta Fed’s nowcast of the GDP growth rate for now current 2024-Q1 will begin on 26 January 2024.

    Image credit: Microsoft Bing Image Creator. Prompt: “editorial cartoon of a bull running away from a boy who is selling newspapers, with the boy running behind the bull, both running up a hill”. The AI didn’t quite get it, but we rather liked this image of the bull running after the boy shouting bad headlines.



    Source: https://politicalcalculations.blogspot.com/2024/01/s-500-chases-after-bad-news-toward-new.html


    Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

    Anyone can join.
    Anyone can contribute.
    Anyone can become informed about their world.

    "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

    Lion’s Mane Mushroom

    Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.



    Our Formula includes:

    Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.

    Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.

    Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.

    Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.

    Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.

    Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.

    Report abuse

      Comments

      Your Comments
      Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

      MOST RECENT
      Load more ...

      SignUp

      Login

      Newsletter

      Email this story
      Email this story

      If you really want to ban this commenter, please write down the reason:

      If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.